SignatureFD’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

SignatureFD’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-122	Closed	-$1.64K	–	3400
2023 Q1	$1.64K	Buy	122 +91	+294%	+$1.57K	﹤0.01%	2861
2022 Q4	$383	Buy	31 +17	+121%	+$241	﹤0.01%	3138
2022 Q3	$0	Buy	+14	New	+$225	﹤0.01%	3418
2022 Q1	–	Sell	-211	Closed	-$3K	–	3374
2021 Q4	$3K	Buy	+211	New	+$3.56K	﹤0.01%	2641
2020 Q4	–	Sell	-25	Closed	-$1K	–	2745
2020 Q3	$1K	Buy	+25	New	+$1.15K	﹤0.01%	2534

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

SignatureFD's ICPT Position: Q2 2023 in Review

SignatureFD sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 122 shares — an estimated $1.64K sold.

SignatureFD first reported a position in ICPT in Q3 2020 and held it in 5 quarters. The position peaked at $3K in Q4 2021. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

SignatureFD reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
SignatureFD sold 122 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $1.64K.
SignatureFD first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2020 and held it in 5 quarters.
SignatureFD's Intercept Pharmaceuticals, Inc. position peaked at $3K in Q4 2021.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on SignatureFD's 13F filing for Q2 2023, filed 1 Aug 2023.